Shukra Pharmaceuticals Board of Directors
Get the latest insights into the leadership at Shukra Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Dakshesh Rameshchandra Shah | Managing Director |
| Mrs. Payal Sujay Mehta | Executive Director |
| Mr. Dhruvin Shah | Whole Time Director |
| Mr. Sanskruti Jayeshbhai Patel | Whole Time Director |
| Mrs. Anar Jayeshbhai Patel | Whole Time Director |
| Mrs. Bhoomiben Patel | Independent Director |
| Mrs. Sonal Deepalbhai Gandhi | Independent Director |
| Mr. Sarjeevan Singh Rathore | Independent Director |
| Mr. Jitendra Somchand Shah | Independent Director |
| Mrs. Pinki Nirmal Sagar | Independent Director |
Shukra Pharmaceuticals Share price
SHUKRAPHAR
28.36
0.55 (1.98%)Last updated on 4 Sep, 2025 | 15:15 IST
BUYSELL
Today's High
28.36
Today's Low
28.36
52 Week Low
5.75
52 Week High
28.36
The current prices are delayed, login to your account for live prices
LoginShukra Pharmaceuticals FAQs
The board at Shukra Pharmaceuticals consists of experienced professionals, including Mr. Dakshesh Rameshchandra Shah , Mrs. Payal Sujay Mehta , and others, overseeing the company’s strategic and corporate governance.
Directors at Shukra Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Dakshesh Rameshchandra Shah is the current chairman at Shukra Pharmaceuticals.
Executive directors at Shukra Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Shukra Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Shukra Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.